Signaling
Science NewsView All Science News
02/05/2019 | AHA's Science News for ISC 2019 in Honolulu, Hawaii, Feb. 6-8, 2019. In-depth interviews and a deep-dive look into studies presented at t...
01/22/2019 | CIRCULATION RESEARCH Featured articles for January 2019
01/16/2019 | CIRCULATION: CARDIOVASCULAR QUALITY AND OUTCOMES 2018 Altmetrics Top Articles
Vascular Discovery: From Genes to Medicine 2019
May 14–16, 2019
Boston, Massachusetts
Related Councils
Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB)
The Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) contributes to the mission and objectives of the American Heart Association (AHA) through efforts in the fields of arteriosclerosis, thrombosis and vascular biology. The council advances and coordinates research, addresses prevention, improves methods for diagnosis and treatment, and works actively with other organizations concerned with these issues. The council disseminates reliable information related to these fields through its annual conference, many awards and lectures, and the AHA's journal, Arteriosclerosis, Thrombosis, and Vascular Biology.
Mary Sorci-Thomas, PhD, FAHA
Chair, Council on Arteriosclerosis, Thrombosis and Vascular Biology
Council on Basic Cardiovascular Sciences (BCVS)
The American Heart Association (AHA) created the Council on Basic Cardiovascular Sciences (BCVS) in 1999 to promote research and education. Our goal is to improve understanding of mechanisms of basic cardiovascular regulation to support the development of new therapies and insights into clinical cardiovascular disease. Special emphasis is placed on integrating molecular/cellular and physiological approaches to address problems relating to functional genomics, cell signaling, myocardial biology, circulatory physiology, pathophysiology and peripheral vascular disease.
Joseph C. Wu, MD, PhD, FAHA
Chair, Council on Basic Cardiovascular Sciences
Council on Genomic and Precision Medicine (GPM)
The mission of the American Heart Association Council on Genomic and Precision Medicine (GPM) is to advance the discovery and translation of biological insights gained from genetics and omics technologies to improve cardiovascular and brain health. Our constituency’s expertise spans across genetics, genomics, epigenetics, transcriptomics, metabolomics, proteomics, microbiome, bioinformatics, computational science, population health, clinical genetics and genomic medicine, with the ultimate goal of more precise risk prediction, treatment and prevention for patients and the population. Integral to the American Heart Association’s goals, the GPM Council provides a premier inter-disciplinary forum promoting and integrating new knowledge from molecules to populations in translational cardiovascular science and precision medicine.
Thomas J. Wang, MD, FAHA
Chair, Council on Genomic and Precision Medicine
Council on Peripheral Vascular Disease (PVD)
The Council on Peripheral Vascular Disease (PVD) seeks to integrate the academic and clinical missions of all interdisciplinary vascular health professionals in order to expand professional and public vascular education; to advance the basic science and clinical research and evidence based practice; and to thereby improve clinical outcomes of individuals with PVD.
Aruna D. Pradhan, MD, MPH
Chair, Council on Peripheral Vascular Disease
Heart disease is the No. 1 killer of women, claiming more lives each year than all forms of cancer combined? But nearly 80 percent of cardiac events can be prevented with education and lifestyle changes.
Visit GoRedforWomen.org (opens in a new window) to learn more and connect with Go Red for Women on Facebook and Twitter.